癌症中的表型可塑性,非遗传机制和免疫药物耐药性
Prakash Kulkarni1,2, Sravani Ramisetty1, Debora Bruno3
1Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.
Cancer treatment and research
|August 23, 2025
概括
癌症免疫疗法利用免疫系统对抗癌症, 了解非遗传机制和采用团队医学方法可以提高治疗效率和个性化.
科学领域:
- 癌症学
- 免疫学
- 遗传学
背景情况:
- 癌症免疫疗法是一个重大突破, 利用患者的免疫系统向癌细胞.
- 包括T细胞治疗和免疫检查点抑制剂在内的各种免疫疗法在治疗转移性疾病方面具有前景.
- 结合免疫疗法与化疗和向治疗的结合疗法正在扩大治疗选择.
研究的目的:
- 总结癌症免疫疗法耐药性的机制,重点关注表型可塑性和非遗传因素.
- 讨论预防复发和提高免疫疗法的策略.
- 突出"团队医学"在个性化癌症免疫治疗中的作用.
主要方法:
- 对癌症免疫疗法耐药性机制的当前文献的审查.
- 对表型可塑性和导致治疗失败的非遗传因素的分析.
- 探索预防复发和个性化治疗的新兴策略.
主要成果:
- 确定了表型可塑性和非遗传机制作为免疫疗法耐药性的关键驱动因素.
- 讨论了预防治疗后复发的最新进展.
- 强调跨学科合作对个性化免疫治疗的重要性.
结论:
- 克服免疫疗法耐药性需要了解复杂的非遗传机制.
- 以团队医疗为指导的个性化治疗策略对于改善患者的结果至关重要.
- 需要对预测生物标志物和新疗法组合进行进一步的研究.
更多相关视频
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.2K
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
6.5K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Development of Antibiotic Resistance
197
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
197
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Transduction
98
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
98
Cell-mediated Immune Responses
72.4K
Overview
72.4K
